• 1
    Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; 81: 64656.
  • 2
    Towheed T, Maxwell L, Judd M, Catton M, Hochberg MC, Wells GA. Acetaminophen for osteoarthritis [review]. Cochrane Database Syst Rev 2006; 1: 167.
  • 3
    Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis 2004; 63: 90127.
  • 4
    Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 2008; 103: 2890907.
    Direct Link:
  • 5
    Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Tauber KA, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians. A scientific statement from the American Heart Association. Circulation 2007; 115: 163442.
  • 6
    Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342: c7086.
  • 7
    Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 25763.
  • 8
    American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 190515.
  • 9
    Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Ann Rheum Dis 2003; 62: 114555.
  • 10
    Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 13762.
  • 11
    Barozzi N, Tett SE. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia? Pharmacoepidemiol Drug Saf 2007; 16: 118491.
  • 12
    Jordan KM, Sawyer S, Coakley P, Smith HE, Cooper C, Arden NK. The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology (Oxford) 2004; 43: 3814.
  • 13
    Linsell L, Dawson J, Zondervan K, Randall T, Rose P, Carr A, et al. Prospective study of elderly people comparing treatments following first primary care consultation for a symptomatic hip or knee. Fam Pract 2005; 22: 11825.
  • 14
    Duran-Barragan S, Russell AS. Use of nonsteroidal anti-inflammatory drugs and coxibs in the elderly: are we following the guidelines [editorial]? Clin Rheumatol 2008; 27: 10812.
  • 15
    Zochling J, March LM, Lapsley H, Cross M, Tribe K, Brooks P. Use of complimentary medicines for osteoarthritis: a prospective study. Ann Rheum Dis 2004; 63: 54954.
  • 16
    Barozzi N, Tett SE. Perceived barriers to paracetamol (acetaminophen) prescribing, especially after rofecoxib withdrawal from the market. Clin Rheumatol 2009; 28: 50919.
  • 17
    Bower KN, Frail D, Twohig PL, Putnam W. What influences seniors' choice of medications for osteoarthritis? Can Fam Physician 2006; 52: 3423.
  • 18
    Carnes D, Anwer Y, Underwood M, Harding G, Parsons S, for the TOIB Study Team. Influences on older people's decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study. BMJ 2008; 336: 1425.
  • 19
    Mikhail SS, Zwar NA, Vagholkar S, Dennis SM, Day RO. Non-steroidal anti-inflammatory drugs in general practice: a decision-making dilemma. Med J Aust 2007; 187: 1603.
  • 20
    Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision making? Soc Sci Med 1992; 34: 50713.
  • 21
    Milder TY, Williams KM, Ritchie JE, Lipworth WL, Day RO. Use of NSAIDs for osteoarthritis amongst older-aged primary-care patients: engagement with information and perceptions of risk. Age Ageing 2011; 40: 2549.
  • 22
    Britt H, Miller GC, Charles J, Henderson J, Bayram C, Harrison C, et al. General practice activity in Australia 2007-08. Canberra: Australian Institute of Health and Welfare; 2008.
  • 23
    National Prescribing Service (NPS). Analgesic choices in persistent pain. Sydney: National Prescribing Service Limited; 2006.
  • 24
    Patton M. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks (CA): Sage Publications; 2002.
  • 25
    Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage Publications; 2006.
  • 26
    Sale JE, Gignac M, Hawker G. How “bad” does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis. Arthritis Rheum 2006; 55: 2728.
  • 27
    Hurley MV, Walsh N, Bhavnani N, Britten N, Stevenson F. Health beliefs before and after participation on an exercise-based rehabilitation programme for chronic knee pain: doing is believing. BMC Musculoskelet Disord 2010; 11: 31.
  • 28
    Jinks C, Ong BN, Richardson J. A mixed methods study to investigate needs assessment for knee pain and disability: population and individual perspectives. BMC Musculoskelet Disord 2007; 8: 59.
  • 29
    Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005; 61: 13355.
  • 30
    Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 2006; 282: 145865.
  • 31
    Cavazos J, Naik AD, Woofter A, Abraham NS. Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study. Aliment Pharmacol Ther 2008; 28: 78998.
  • 32
    Juby AG, Davis P. Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly. Clin Rheumatol 2008; 27: 11914.
  • 33
    Commonwealth Department of Health and Ageing. The national strategy for quality use of medicines. Canberra: Commonwealth of Australia; 2002.
  • 34
    Britten N, Stevenson F, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ 2000; 320: 4848.
  • 35
    Klein D, MacDonald A, Drummond N, Cave A. A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal conditions. Fam Pract 2006; 23: 65965.
  • 36
    Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM, et al. Factors that influence prescribing decisions. Ann Pharmacother 2004; 38: 55762.